Acute vasomotor paralysis and potential downstream effects of paclitaxel from stents implanted for saphenous vein aorto-coronary bypass stenosis

Basic Research in Cardiology

Volumn 106, Issue 4, 2011, Pages 681-689

  Kleinbongard, Petra ^a   Böse, Dirk ^a   Konorza, Thomas ^a   Steinhilber, Florian ^a   Möhlenkamp, Stefan ^a   Eggebrecht, Holger ^a   Baars, Theodor ^a   Degen, Hubertus ^b   Haude, Michael ^b   Levkau, Bodo ^a   Erbel, Raimund ^a   Heusch, Gerd ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b Lukaskrankenhaus GmbH   (Germany)

Author keywords

Coronary disease; Stents; Vasoconstriction; Vasodilation

Indexed keywords

PACLITAXEL; RAPAMYCIN; SEROTONIN; THROMBOXANE B2;

AGED; ANIMAL TISSUE; ARTICLE; BARE METAL STENT; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; HUMAN; MALE; MESENTERIC ARTERY; MICROTUBULE; NONHUMAN; PROTEIN BLOOD LEVEL; RAT; SAPHENOUS VEIN GRAFT; SAPHENOUS VEIN GRAFT STENOSIS; SEROTONIN BLOOD LEVEL; SEROTONIN RELEASE; THROMBOXANE B2 BLOOD LEVEL; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; VEIN GRAFT DISEASE;

AGED; ANIMALS; CORONARY ARTERY BYPASS; CORONARY STENOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; PACLITAXEL; RATS; RATS, INBRED LEW; SAPHENOUS VEIN; SEROTONIN; THROMBOXANE B2; VASOCONSTRICTION;

EID: 79959742539     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-011-0177-9     Document Type: Article

References (27)

1. G Heusch P Kleinbongard D Böse B Levkau M Haude R Schulz R Erbel 2009 Coronary microembolization: from bedside to bench and back to bedside Circulation 120 1822 1836
2. K Leineweber D Böse M Vogelsang M Haude R Erbel G Heusch 2006 Intense vasoconstriction in response to aspirate from stented saphenous vein aortocoronary bypass grafts J Am Coll Cardiol 47 981 986
3. P Kleinbongard D Böse T Baars S Möhlenkamp T Konorza S Schöner M Elter-Schulz H Eggebrecht H Degen M Haude B Levkau R Schulz R Erbel G Heusch 2010 Vasoconstrictor potential of coronary aspirate from patients undergoing stenting of saphenous vein aortocoronary bypass grafts and its pharmacological attenuation Circ Res 108 344 352
4. DJ Malenka AV Kaplan FL Lucas SM Sharp JS Skinner 2008 Outcomes following coronary stenting in the era of bare-metal vs the era of drug-eluting stents JAMA 299 2868 2876 (Pubitemid 351930886)
5. S Silber M Borggrefe M Böhm HM Hoffmeister R Dietz G Ertl G Heusch 2008 Medikamente freisetzende Koronarstents (DES) und Medikamente freisetzende Ballonkatheter (DEB): Aktualisierung des Positionspapiers der DGK Clin Res Cardiol 97 548 563
6. CA Nienaber I Akin S Schneider J Senges T Fetsch U Tebbe SN Willich J Stumpf GV Sabin S Silber G Richardt KH Kuck 2009 Clinical outcomes after sirolimus-eluting, paclitaxel-eluting and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry) Am J Cardiol 104 1362 1369
7. M Togni L Raber R Cocchia P Wenaweser S Cook S Windecker B Meier OM Hess 2007 Local vascular dysfunction after coronary paclitaxel-eluting stent implantation Int J Cardiol 120 212 220 (Pubitemid 47042255)
8. M Hamilos J Sarma M Ostojic T Cuisset G Sarno N Melikian A Ntalianis O Muller E Barbato B Beleslin D Sagic BB De J Bartunek W Wijns 2008 Interference of drug-eluting stents with endothelium-dependent coronary vasomotion: evidence for device-specific responses Circ Cardiovasc Interv 1 193 200
9. M van den Heuvel O Sorop WW Batenburg CL Bakker R de Vries SJ Koopmans HM van Beusekom DJ Duncker AH Danser WJ Van der Giessen, et al. 2010 Specific coronary drug-eluting stents interfere with distal microvascular function after single stent implantation in pigs JACC Cardiovasc Interv 3 723 730
10. LK Pendyala J Li T Shinke S Geva X Yin JP Chen SB King KA Robinson NAF Chronos D Hou 2009 Endothelium-dependent vasomotor dysfunction in pig coronary arteries with paclitaxel-eluting stents is associated with inflammation and oxidative stress JACC Cardiovasc Interv 2 253 262
11. SH Platts JC Falcone WT Holton MA Hill GA Meininger 1999 Alteration of microtubule polymerization modulates arteriolar vasomotor tone Am J Physiol 277 H100 H106
12. D Zhang N Jin RA Rhoades KW Yancey DR Swartz 2000 Influence of microtubules on vascular smooth muscle contraction J Muscle Res Cell Motil 21 293 300 (Pubitemid 30598783)
13. F Catella D Healy JA Lawson GA FitzGerald 1986 11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation Proc Natl Acad Sci USA 83 5861 5865 (Pubitemid 16000613)
14. AH Chester SP Allen S Tadjkarimi MH Yacoub 1993 Interaction between thromboxane A2 and 5-hydroxytryptamine receptor subtypes in human coronary arteries Circulation 87 874 880 (Pubitemid 23070819)
15. Y Nishimura 1996 Characterization of 5-hydroxytryptamine receptors mediating contractions in basilar arteries from stroke-prone spontaneously hypertensive rats Br J Pharmacol 117 1325 1333 (Pubitemid 26105358)
16. J Bauer C Dau A Cavarape F Schaefer H Ehmke N Parekh 1999 ANG II- and TxA(2)-induced mesenteric vasoconstriction in rats is mediated by separate cell signaling pathways Am J Physiol 277 H1 H7
17. T Nilsson J Longmore D Shaw E Pantev JA Bard T Branchek L Edvinsson 1999 Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques Eur J Pharmacol 372 49 56 (Pubitemid 29229863)
18. MJ Mulvany W Halpern 1977 Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats Circ Res 41 19 26 (Pubitemid 8132079)
19. MJ Mulvany DM Warshaw 1979 The active tension-length curve of vascular smooth muscle related to its cellular components J Gen Physiol 74 85 104 (Pubitemid 9220542)
20. KR Kamath JJ Barry KM Miller 2006 The Taxus drug-eluting stent: a new paradigm in controlled drug delivery Adv Drug Deliv Rev 58 412 436 (Pubitemid 43949060)
21. R Leite RC Webb 1998 Microtubule disruption potentiates phenylephrine-induced vasoconstriction in rat mesenteric arterial bed Eur J Pharmacol 351 R1 R3
22. DI Shin PJ Kim KB Seung DB Kim MJ Kim K Chang SM Lim DS Jeon WS Chung SH Baek MY Lee 2007 Drug-eluting stent implantation could be associated with long-term coronary endothelial dysfunction Int Heart J 48 553 567
23. M Unverdorben C Vallbracht B Cremers H Heuer C Hengstenberg C Maikowski GS Werner D Antoni FX Kleber W Bocksch M Leschke H Ackermann M Boxberger U Speck R Degenhardt B Scheller 2009 Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis Circulation 119 2986 2994
24. M Unverdorben FX Kleber H Heuer HR Figulla C Vallbracht M Leschke B Cremers S Hardt M Buerke H Ackermann M Boxberger R Degenhardt B Scheller 2010 Treatment of small coronary arteries with a paclitaxel-coated balloon catheter Clin Res Cardiol 99 165 174
25. BM Kaplan KH Benzuly JW Kinn TR Bowers FV Tilli CL Grines WW O'Neill RD Safian 1996 Treatment of no-reflow in degenerated saphenous vein graft interventions: comparison of intracoronary verapamil and nitroglycerin Cathet Cardiovasc Diagn 39 113 118
26. S Sdringola AR Assali M Ghani A Moustapha H Achour SW Yusuf K Fujise O Rosales GW Schroth HV Anderson RW Smalling 2001 Risk assessment of slow or no-reflow phenomenon in aortocoronary vein graft percutaneous intervention Catheter Cardiovasc Interv 54 318 324
27. AD Michaels M Appleby MH Otten K Dauterman TA Ports TM Chou CM Gibson 2002 Pretreatment with intragraft verapamil prior to percutaneous coronary intervention of saphenous vein graft lesions: results of the randomized, controlled vasodilator prevention on no-reflow (VAPOR) trial J Invasive Cardiol 14 299 302 (Pubitemid 34651235)